FDA.reportPublic FDA data

Application 205622

Type
ANDA
Sponsor
MYLAN TECHNOLOGIES

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RIVASTIGMINERIVASTIGMINEFILM, EXTENDED RELEASE;TRANSDERMAL4.6MG/24HRNoNo
002RIVASTIGMINERIVASTIGMINEFILM, EXTENDED RELEASE;TRANSDERMAL9.5MG/24HRNoNo
003RIVASTIGMINERIVASTIGMINEFILM, EXTENDED RELEASE;TRANSDERMAL13.3MG/24HRNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0378-9070RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9070RivastigminerivastigmineMylan Pharmaceuticals IncANDACurrent
0378-9070RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9070RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9070RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9070RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9071RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9071RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9071RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9071RivastigminerivastigmineMylan Pharmaceuticals IncANDACurrent
0378-9071RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9071RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9072RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9072RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9072RivastigminerivastigmineMylan Pharmaceuticals IncANDACurrent
0378-9072RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9072RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent
0378-9072RivastigminerivastigmineMylan Pharmaceuticals Inc.ANDACurrent